Today, crystallization is used primarily to analyze the structures of proteins. It also is gaining favor as a purification method for elastase, proteases, albumin, and lipase, in addition to ...
Over the years, bioprocessors could, at various times, debate whether upstream or downstream operations represented the slow step, relatively speaking, of therapeutic protein production. Now, with ...
Launching at the Festival of Biologics, ShunzymeX is designed to streamline process development and accelerate GMP readiness for complex biologics. TEESSIDE, England--(BUSINESS WIRE)--FUJIFILM ...
FUJIFILM Biotechnologies introduces ShunzymeX precision purification technology for downstream processing of complex biologics: Teessid, United Kingdom Thursday, March 5, 2026, 16 ...
Creative Biolabs announces upgraded downstream services designed to bridge the gap between raw antibody expression and advanced preclinical development. SHIRLEY, NY ...
FUJIFILM Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, today unveils ShunzymeX precision purification ...
“The efficiency of downstream processing determines the ultimate viability of a lead candidate,” says Dr. Simon Hu, Chief Scientific Officer at Creative Biolabs. “Our goal is to provide a seamless ...